The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis

Clinical and Experimental Dermatology

Volumn 40, Issue 6, 2015, Pages 665-671

  Heo, W I ^a   Lee, K E ^a   Hong, J Y ^a   Kim, M N ^a   Oh, M S ^a   Kim, Y S ^a   Kim, K W ^a   Kim, K E ^a   Sohn, M H ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; MESSENGER RNA; OXAZOLONE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CONFOCAL MICROSCOPY; CONTACT DERMATITIS; CONTROLLED STUDY; EAR EDEMA; EAR SWELLING; ELECTRON MICROSCOPY; FEMALE; HUMIDITY METER; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATORY CELL; LAMELLAR BODY; MOUSE; MOUSE MODEL; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SKIN BARRIER DYSFUNCTION; SKIN BIOPSY; SKIN DISEASE; SKIN PERMEABILITY; SKIN WATER LOSS; SWELLING; TH2 CELL; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; EAR; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; THERMOREGULATION;

ANIMALS; CYTOKINES; DERMATITIS, ATOPIC; DERMATITIS, CONTACT; DISEASE MODELS, ANIMAL; EAR; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; REAL-TIME POLYMERASE CHAIN REACTION; TH2 CELLS; WATER LOSS, INSENSIBLE;

EID: 84937631871     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12567     Document Type: Article

References (24)

1. Mittermann I, Aichberger KJ, Bunder R, et al,. Autoimmunity and atopic dermatitis. Curr Opin Allergy Clin Immunol 2004; 4: 367-71.
2. Smith Pease CK, Basketter DA, Patlewicz GY,. Contact allergy: the role of skin chemistry and metabolism. Clin Exp Dermatol 2003; 28: 177-83.
3. Jin H, He R, Oyoshi M, Geha RS,. Animal models of atopic dermatitis. J Invest Dermatol 2009; 129: 31-40.
4. Cork MJ, Danby SG, Vasilopoulos Y, et al,. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009; 129: 1892-908.
5. Akhavan A, Cohen SR,. The relationship between atopic dermatitis and contact dermatitis. Clin Dermatol 2003; 21: 158-62.
6. Man MQ, Hatano Y, Lee SH, et al,. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 2008; 128: 79-86.
7. Koga C, Kabashima K, Shiraishi N, et al,. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008; 128: 2625-30.
8. Di Cesare A, Di Meglio P, Nestle FO,. A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J Invest Dermatol 2008; 128: 2569-71.
9. Pappu R, Ramirez-Carrozzi V, Ota N, et al,. The IL-17 family cytokines in immunity and disease. J Clin Immunol 2010; 30: 185-95.
10. van Beelen AJ, Teunissen MB, Kapsenberg ML, et al,. Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol 2007; 7: 374-81.
11. Toda M, Leung DY, Molet S, et al,. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 2003; 111: 875-81.
12. Proksch E, Folster-Holst R, Brautigam M, et al,. Role of the epidermal barrier in atopic dermatitis. J Dtsch Dermatol Ges 2009; 7: 899-910.
13. Feingold KR, Denda M,. Regulation of permeability barrier homeostasis. Clin Dermatol 2012; 30: 263-8.
14. Proksch E, Brasch J,. Abnormal epidermal barrier in the pathogenesis of contact dermatitis. Clin Dermatol 2012; 30: 335-44.
15. Nakae S, Komiyama Y, Nambu A, et al,. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002; 17: 375-87.
16. Park SY, Gupta D, Kim CH, et al,. Differential effects of peptidoglycan recognition proteins on experimental atopic and contact dermatitis mediated by Treg and Th17 cells. PLoS One 2011; 6: e24961.
17. Tokura Y, Mori T, Hino R,. Psoriasis and other Th17-mediated skin diseases. J UOEH 2010; 32: 317-28.
18. Cheung PF, Wong CK, Lam CW,. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol 2008; 180: 5625-35.
19. Schmuth M, Yosipovitch G, Williams ML, et al,. Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol 2001; 117: 837-47.
20. Li C, Lasse S, Lee P, et al,. Development of atopic dermatitis-like skin disease from the chronic loss of epidermal caspase-8. Proc Natl Acad Sci USA 2010; 107: 22249-54.
21. Hanifin JM,. Filaggrin mutations and allergic contact sensitization. J Invest Dermatol 2008; 128: 1362-4.
22. Thyssen JP, Linneberg A, Ross-Hansen K, et al,. Filaggrin mutations are strongly associated with contact sensitization in individuals with dermatitis. Contact Derm 2013; 68: 273-6.
23. Gutowska-Owsiak D, Schaupp AL, Salimi M, et al,. IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion. Exp Dermatol 2012; 21: 104-10.
24. Chiricozzi A, Nograles KE, Johnson-Huang LM, et al,. IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model. PLoS One 2014; 9: e90284.